Rapamycin, which is the other name for Sirolimus drug is very useful in organ transplant and is used to reduce organ rejection. It has additional use in the treatment of some rear lung disease and for certain cancer drug. The common name used for it in the market is Rapamune. The drug was first discovered and extracted from some bacterium found on the Easter Island. Before the discovery of its extended importance in the medical field, Sirolimus was used as the anti fungal drug. Its use as the antifungal drug was held back when the scientist discovered it’s immunosuppressive and antiproliferative properties. Mikhail Blagosklonny is a scientist that has carried out a lot of research on cancer and its therapies. He is a professor at Roswell Park Cancer Institute in Buffalo. He has majored his studies in the aspect of aging as he works as the chief editor of the Oncotarget. He is known for his diverse research on the possibility of using Rapamycin to increase the lifespan of an individual.
Rapamycin has superior properties over the ordinary immunosuppressive drugs and calcineurin inhibitors. These commonly used drugs that are usually prescribed by physicians to prevent the rejection of an organ by the body have a long-term adverse effect towards the kidneys. Rapamycin lowers the risk of suffering from the toxins towards the kidneys. Rapamycin is also used to reduce the chances of the transplanted kidney from contracting the hemolytic-uremic disease. This is a rare disease that comes with the combination of kidney failure, anemia, and low platelets count. A kidney transplant is the only solution, and under the prescription of calcineurin inhibitors, the kidney may also be at risk of getting the infection.Mikhail Blagosklonny works as a researcher in his career and is also famous for his philanthropic activities. He is an average man determined to work in ensuring that all people can access the best treatment procedure regardless of the economic status of the individual.
Mikhail Blagosklonny’s interest in research is on the cancer intervention and aging. The sheer interest on the two is brought about by the fact that cancer becomes prevalent in old age above a certain age. Mikhail Blagosklonny’s research is so important and will continue to be an important aspect of scientific research in the future in oncology field. Mikhail Blagosklonny is also a very influential individual in his field as he influences his colleagues and students making them aspire to move on to higher in their fields of studies. The impact of the field of research that Mikhail Blagosklonny is undertaking that regards cancer and aging have attracted much attention in the field and has been published in the impactjournal.com. The main goal in his mind is to come up with a way of treating cancer and in the most effective way that will be cheap and affordable much more than it is nowadays. Furthermore, he is working in a way in which the cancerous cells in the body can be got rid of the body without interfering with the other cells that are crucial in the recovery after long periods of cancer treatment.